Selected article for: "activity relationship and small molecule"
Author: Adhikari, Nilanjan; Baidya, Sandip K.; Saha, Achintya; Jha, Tarun
Title: Structural Insight Into the Viral 3C-Like Protease Inhibitors: Comparative SAR/QSAR Approaches
  • Cord-id: z6v6s46n
  • Document date: 2017_7_14
    • ID: z6v6s46n
    Snippet: Severe acute respiratory syndrome (SARS), caused by SARS-coronavirus (SARS-CoV), is a dreadful infection worldwide having economic and medical importance and a global threat for health. It was turned into an epidemic in South China followed by a chain of infections across three generations. A number of pathogeneses in human may occur due to the virus. This infection has not been taken into account before the SARS outbreak, and still it is a neglected one. Therefore, there is an urgent need to de
    Document: Severe acute respiratory syndrome (SARS), caused by SARS-coronavirus (SARS-CoV), is a dreadful infection worldwide having economic and medical importance and a global threat for health. It was turned into an epidemic in South China followed by a chain of infections across three generations. A number of pathogeneses in human may occur due to the virus. This infection has not been taken into account before the SARS outbreak, and still it is a neglected one. Therefore, there is an urgent need to develop small molecule antivirals to combat the SARS-CoV. No vaccines are available till date though a number of SARS-CoV 3C-like and 3C protease inhibitors were reported. In this chapter, quantitative structure–activity relationship technique is used for development of anti-SARS and anti-HRV drugs and outcome discussed in details. This approach may be a useful strategy to design novel and potential anti-SARS drugs to combat these dreadful viral diseases.

    Search related documents:
    Co phrase search for related documents
    • absence presence and active site: 1, 2, 3, 4, 5, 6, 7, 8
    • absence presence and active site residue: 1
    • absence presence and active surface: 1
    • absence presence and activity affect: 1
    • absence presence and activity control: 1, 2, 3
    • absence presence and activity crucial: 1
    • absence presence and activity decrease: 1
    • absence presence and activity increase: 1, 2, 3
    • absence presence and activity influence: 1
    • absence presence and activity lower: 1, 2
    • absence presence and activity reduce: 1
    • absence presence and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
    • absence presence and low activity: 1, 2, 3
    • absence presence and low volume: 1, 2
    • acceptor type and active site: 1
    • acceptor type and activity affect: 1